A plain look at NMN as an NAD+ precursor: what small human trials found, the doses used, safety, how it stacks up against NR and NMNH, and what to check on a label.
NMN (nicotinamide mononucleotide) is a type of vitamin B3, and the body turns it into NAD+. In small, short placebo-controlled trials using 250 to 1,250 mg a day, it consistently raised NAD+ in the blood and people tolerated it well. Results on health measures were modest and mixed. NMN makers paid for several of the trials, and no human study has shown that NMN slows aging.
Cells need NAD+, a coenzyme, to turn food into energy and to run enzymes tied to DNA repair and cell signaling. NMN is a nucleotide the body uses to build it. Small amounts turn up in foods like broccoli, avocado and edamame, but supplements deliver much more. The FDA said in September 2025 that NMN can be sold as a dietary supplement in the US.
There are only a handful of placebo-controlled trials in people. Most enrolled roughly 10 to 110 participants, ran 2 to 12 weeks and used 250 to 1,250 mg a day. Blood NAD+ rose reliably. Some also saw modest shifts. In a small US trial (Yoshino et al., 2021), 25 postmenopausal women with prediabetes took 250 mg a day for 10 weeks and showed better muscle insulin sensitivity; other trials noted changes in walking distance or grip strength. Still, the picture is mixed, NMN ingredient makers funded several of the trials, and none looked at aging itself. Animal work suggests NAD+ declines with age, yet what that means for people remains unclear.
Nicotinamide riboside (NR) is closely related. Both are vitamin B3 forms, with NR sitting one step earlier on the route to NAD+. More human research exists for NR, although company funding is common there and gains beyond a higher NAD+ level are limited. Nobody has published a head-to-head trial of NMN and NR in people.
NMNH is a reduced version of NMN. Work in cells and mice hints that it lifts NAD+ more than NMN does. We found no peer-reviewed human trial, though, and no published data showing better stability. Findings from human studies of regular NMN can't simply be carried over to NMNH.
Short trials found NMN well tolerated at 250 to 2,000 mg a day, with side effects no more frequent than on placebo. Long-term safety isn't known. See your doctor first if you're pregnant, in cancer treatment, or on diabetes or blood pressure medicines. Our top pick among NMN supplements is GenuinePurity Liposomal NMN: 500 mg per 2-capsule serving, backed by a 97-day guarantee (counted from delivery, with conditions). The product itself has not been tested in a trial.